Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tenascin C Antibody (SPM319) - IHC-Prediluted, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP248457
Description
Tenascin C Monoclonal specifically detects Tenascin C in Human, Rat (Negative) samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
Tenascin C | |
Monoclonal | |
Unconjugated | |
1.0mM PBS and 0.05% BSA with 0.05% Sodium Azide | |
TNC | |
Human breast carcinoma (Uniprot: P24821) | |
7 mL | |
Breast Cancer, Cancer, Extracellular Matrix, Neuroscience, Prostate Cancer | |
3371 | |
Human, Rat (Negative) | |
Purified |
Immunohistochemistry (Paraffin) | |
SPM319 | |
Immunohistochemistry-Paraffin | |
150-225, Cytotactin, Glioma-associated-extracellular matrix antigen, GMEM, GP 150-225, Hexabrachion, hexabrachion (tenascin C, cytotactin), hexabrachion (tenascin), HXBcytotactin, JI, MGC167029, Myotendinous antigen, neuronectin, tenascin, tenascin C, Tenascin-C, tenascin-C isoform 14/AD1/16, TN-C, TNGP | |
Mouse | |
Protein A or G purified | |
RUO | |
Primary | |
In Western blotting, it reacts with two bands of ∼MW of 210kDa and 300kDa, identified as two isoforms of Tenascin C. Specificity of this monoclonal antibody is validated by sequential immunoprecipitation with a PAb against Tenascin C. Tenascin C is a multifunctional, disulfide-linkedhexameric extracellular matrix glycoprotein expressed in association with mesenchymal epithelial interactions during development and in the neo-vasculature and stroma of undifferentiated tumors. In adults, it is restricted to certain epithelial-stromal interfaces and increases markedly in hyper-proliferative diseases and in stroma of many neoplasms, including gliomas, breast, squamous and lung carcinomas. | |
Store at 4C. | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction